Why the study?
Does the administration of neuroleptics in patients with an agitated response to antidepressants increase the risk of Neuroleptic Malignant Syndrome?
Does the administration of neuroleptics in patients with an agitated response to antidepressants increase the risk of Neuroleptic Malignant Syndrome?
An agitated response to antidepressants may precede neuroleptic malignant syndrome, suggesting that neuroleptics should be used with caution in such patients due to a potential relative norepinephrine/dopamine excess.
Answers are grounded in this paper and cite their sources.
May warrant caution with neuroleptics after antidepressant agitation; leaves open causal NMS risk, needing prospective study.
The authors present a case report in which an agitated response to antidepressants preceded the neuroleptic malignant syndrome (NMS). In a review of 64 cases of NMS in the literature, they found that 80% were described as agitated prior to the development of the syndrome. Polypharmacy was common. A review of the literature on theories of pathogenesis involving sympathetic amines other than dopamine is presented to explain this phenomena. It is suggested that these toxic reactions to medication can be interpreted as resulting from a relative NE/DA excess, in which antidepressants increase the numerator, while neuroleptics functionally decrease the denominator. It is recommended that where an agitated response to antidepressants is observed, neuroleptics should be used only with considerable caution.
No takes yet. Share an insight, caveat, or question.
Schibuk et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: